Gan & Lee Pharmaceuticals. Statistics

Total Valuation

Gan & Lee Pharmaceuticals. has a market cap or net worth of CNY 28.91 billion. The enterprise value is 23.85 billion.

Market Cap	28.91B
Enterprise Value	23.85B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jun 18, 2024

Share Statistics

Gan & Lee Pharmaceuticals. has 597.09 million shares outstanding. The number of shares has increased by 3.48% in one year.

Current Share Class	n/a
Shares Outstanding	597.09M
Shares Change (YoY)	+3.48%
Shares Change (QoQ)	+8.04%
Owned by Insiders (%)	36.62%
Owned by Institutions (%)	7.64%
Float	300.15M

Valuation Ratios

The trailing PE ratio is 49.11 and the forward PE ratio is 31.04.

PE Ratio	49.11
Forward PE	31.04
PS Ratio	9.68
PB Ratio	2.67
P/TBV Ratio	n/a
P/FCF Ratio	191.79
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 49.40, with an EV/FCF ratio of 158.20.

EV / Earnings	41.06
EV / Sales	8.09
EV / EBITDA	49.40
EV / EBIT	95.53
EV / FCF	158.20

Financial Position

The company has a current ratio of 8.04, with a Debt / Equity ratio of 0.00.

Current Ratio	8.04
Quick Ratio	6.62
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	452.49

Financial Efficiency

Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is 1.48%.

Return on Equity (ROE)	5.51%
Return on Assets (ROA)	1.35%
Return on Capital (ROIC)	1.48%
Revenue Per Employee	657,602
Profits Per Employee	129,598
Employee Count	4,482
Asset Turnover	0.26
Inventory Turnover	0.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.24% in the last 52 weeks. The beta is 1.62, so Gan & Lee Pharmaceuticals.'s price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	+2.24%
50-Day Moving Average	44.81
200-Day Moving Average	44.44
Relative Strength Index (RSI)	57.45
Average Volume (20 Days)	12,318,281

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gan & Lee Pharmaceuticals. had revenue of CNY 2.95 billion and earned 580.86 million in profits. Earnings per share was 0.99.

Revenue	2.95B
Gross Profit	2.15B
Operating Income	249.64M
Pretax Income	558.72M
Net Income	580.86M
EBITDA	478.21M
EBIT	249.64M
Earnings Per Share (EPS)	0.99

Full Income Statement

Balance Sheet

The company has 5.07 billion in cash and 3.67 million in debt, giving a net cash position of 5.06 billion or 8.48 per share.

Cash & Cash Equivalents	5.07B
Total Debt	3.67M
Net Cash	5.06B
Net Cash Per Share	8.48
Equity (Book Value)	11.21B
Book Value Per Share	18.13
Working Capital	5.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 651.75 million and capital expenditures -501.01 million, giving a free cash flow of 150.74 million.

Operating Cash Flow	651.75M
Capital Expenditures	-501.01M
Free Cash Flow	150.74M
FCF Per Share	0.25

Full Cash Flow Statement

Margins

Gross margin is 72.97%, with operating and profit margins of 8.47% and 19.71%.

Gross Margin	72.97%
Operating Margin	8.47%
Pretax Margin	18.96%
Profit Margin	19.71%
EBITDA Margin	16.23%
EBIT Margin	8.47%
FCF Margin	5.11%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.40%.

Dividend Per Share	0.20
Dividend Yield	0.40%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	20.36%
Buyback Yield	-3.48%
Shareholder Yield	-3.08%
Earnings Yield	2.04%
FCF Yield	0.52%

Dividend Details

Stock Splits

The last stock split was on August 20, 2020. It was a forward split with a ratio of 1.4.

Last Split Date	Aug 20, 2020
Split Type	Forward
Split Ratio	1.4

Scores

Gan & Lee Pharmaceuticals. has an Altman Z-Score of 17.49.

Altman Z-Score	17.49
Piotroski F-Score	n/a